Gynecologic oncology practices — treating ovarian, fallopian tube, peritoneal, endometrial, cervical, and vulvar cancers — operate at the junction of complex surgery, systemic therapy, and hereditary cancer medicine. The Society of Gynecologic Oncology (SGO) has consistently highlighted administrative burden as one of the top workforce challenges in the specialty: gynecologic oncologists spend 30% to 40% of their time on administrative tasks, with documentation for genetic testing disclosure, surgical scheduling, NCCN compliance, and survivorship care plans among the most time-consuming. Virtual assistants (VAs) trained in gynecologic oncology workflows are absorbing this burden while ensuring that program quality metrics, accreditation standards, and patient communication obligations are met.
BRCA and Germline Result Disclosure Coordination
SGO and NCCN recommend germline genetic testing for all patients with newly diagnosed ovarian, fallopian tube, or peritoneal cancer, regardless of family history or age. Additionally, endometrial cancer patients meeting Lynch syndrome criteria require germline testing for MLH1, MSH2, MSH6, and PMS2. Coordinating the testing-to-disclosure workflow requires tracking specimen submission, monitoring result availability, scheduling post-result genetic counseling appointments for all positive findings, and documenting that disclosure occurred within the medical record.
VAs maintain germline testing tracking logs for all newly diagnosed patients, monitor result availability through laboratory portals, generate disclosure appointment scheduling requests for the genetic counseling team, and document completion of result disclosure in the EHR. For practices without an embedded genetic counselor, VAs also coordinate referrals to external genetic counseling services and track that patients attended their appointments. SGO's 2024 quality metrics survey found that germline testing completion rates in gynecologic oncology practices using structured coordination workflows were 22 percentage points higher than in practices without dedicated tracking.
NCCN Guideline Adherence Documentation
For CoC-accredited cancer programs and practices participating in SGO's Ovarian Cancer Quality Improvement initiative, NCCN guideline adherence is a reportable quality metric. Documentation requirements include recording the NCCN treatment recommendation discussed at tumor board, the treatment actually administered, and the clinical rationale when treatment deviates from NCCN guidelines. For endometrial cancer, NCCN molecular classification documentation (POLE mutation, MMR-deficiency, TP53 mutation, NSMP) is now an emerging standard that programs must incorporate into their quality reporting.
VAs coordinate NCCN adherence documentation by preparing tumor board case summaries, recording treatment decisions against NCCN pathway recommendations, and flagging cases where deviation rationale documentation is missing. This function supports both accreditation compliance and quality improvement data collection.
Surgical Scheduling for Debulking and HIPEC
Cytoreductive surgery with or without HIPEC (hyperthermic intraperitoneal chemotherapy) for advanced ovarian or appendiceal/peritoneal cancer is among the most complex surgical scheduling challenges in oncology. HIPEC cases require OR time blocks of 8 to 12 hours, perfusionist availability, ICU bed reservation, the chemotherapy agent itself (typically mitomycin C or oxaliplatin) and its preparation, anesthesia team notification, and surgical instrumentation setup. Pre-authorization from commercial payers requires detailed clinical documentation and frequently triggers peer-to-peer review.
VAs manage the pre-scheduling coordination: compiling payer authorization documentation, coordinating OR scheduling with surgical services, confirming perfusionist and ICU availability, and communicating preparation instructions to patients and their families. For practices performing 2 to 4 HIPEC cases per month, this coordination function alone justifies VA support.
Survivorship Care Plan Generation
ASCO and CoC accreditation standards require that patients completing primary cancer treatment receive a survivorship care plan (SCP) documenting their treatment summary, surveillance schedule, late effects risks, and recommended follow-up providers. For gynecologic oncology practices with high patient volumes, generating individualized SCPs is a documentation obligation that clinical staff frequently cannot fulfill consistently.
VAs draft SCPs using standardized templates (ASCO Cancer Treatment Summaries, Journey Forward), pulling treatment data from the EHR, populating the surveillance schedule based on NCCN guidelines, and routing the completed SCP to the physician for review and signature. After approval, VAs ensure the SCP is transmitted to the patient and their primary care provider with documentation of transmission in the medical record.
To explore gynecologic oncology administrative support, visit Stealth Agents.
Sources
- Society of Gynecologic Oncology. "SGO Quality Metrics Survey." 2024.
- National Comprehensive Cancer Network. "NCCN Guidelines: Ovarian Cancer, Endometrial Cancer." 2025.
- American Society of Clinical Oncology. "ASCO Survivorship Care Plan Guidelines." asco.org.
- Commission on Cancer. "CoC Accreditation Standards." facs.org. 2024.